APA

Higuchi T., Soga Y., Muro M., Kajizono M., Kitamura Y., Sendo T. & Sasaki A. (20181113). Replacing zoledronic acid with denosumab is a risk factor for developing osteonecrosis of the jaw. : Oral surgery, oral medicine, oral pathology and oral radiology.

Chicago

Higuchi Tomoko, Soga Yoshihiko, Muro Misato, Kajizono Makoto, Kitamura Yoshihisa, Sendo Toshiaki and Sasaki Akira. 20181113. Replacing zoledronic acid with denosumab is a risk factor for developing osteonecrosis of the jaw. : Oral surgery, oral medicine, oral pathology and oral radiology.

Harvard

Higuchi T., Soga Y., Muro M., Kajizono M., Kitamura Y., Sendo T. and Sasaki A. (20181113). Replacing zoledronic acid with denosumab is a risk factor for developing osteonecrosis of the jaw. : Oral surgery, oral medicine, oral pathology and oral radiology.

MLA

Higuchi Tomoko, Soga Yoshihiko, Muro Misato, Kajizono Makoto, Kitamura Yoshihisa, Sendo Toshiaki and Sasaki Akira. Replacing zoledronic acid with denosumab is a risk factor for developing osteonecrosis of the jaw. : Oral surgery, oral medicine, oral pathology and oral radiology. 20181113.